Mass balance, metabolic disposition, and pharmacokinetics of a novel selective inhibitor of PI3Kδ [14C] SHC014748M in healthy Chinese subjects following oral administration

Authors :: Fei Guo
Bingyan Liu
Xiaoli Li
Haidong Wang
Xingyu Zhu
Yue Su
Cuixia He
Minhui Zhu
Jiaxiang Ding
Yuanyuan Xu
Xiangdi Zhao
Ying Wang
Rongfang Shan
Juan Zhu
Jing Xie
Qin Ge
Ling Fan
Yuzhou Ding
Yunqiu Xie
Chaoyang Zhang
Hongtao Li
Hongju Wang
Huan Zhou
Source :: Cancer Chemotherapy and Pharmacology. 91:143-156
Publication Year :: 2022
Publisher :: Springer Science and Business Media LLC, 2022.

Subjects :: Pharmacology
Cancer Research
Oncology
Pharmacology (medical)
Toxicology

Tools